All News #Library
Rare Diseases
Be Bio’s haemophilia B treatment gains FDA orphan drug status
05 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
FDA: Orphan Status For BE-101 In Hemophilia B Treatment
04 Jun 2024 //
BUSINESSWIRE

Market Place
Sourcing Support